Drug Shortage Report for ASAPHEN
| Report ID | 244817 |
| Drug Identification Number | 02009013 |
| Brand name | ASAPHEN |
| Common or Proper name | ASAPHEN CHEW |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ACETYLSALICYLIC ACID |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET (CHEWABLE) |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N02BA |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-12-03 |
| Estimated end date | 2025-02-21 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-12-20 | French | Compare |
| v5 | 2024-12-20 | English | Compare |
| v4 | 2024-12-04 | French | Compare |
| v3 | 2024-12-04 | English | Compare |
| v2 | 2024-12-04 | French | Compare |
| v1 | 2024-12-04 | English | Compare |
Showing 1 to 6 of 6